Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.9%

18 terminated/withdrawn out of 926 trials

Success Rate

88.5%

+1.9% vs industry average

Late-Stage Pipeline

11%

104 trials in Phase 3/4

Results Transparency

7%

10 of 139 completed trials have results

Key Signals

266 recruiting10 with results11 terminated7 withdrawn

Enrollment Performance

Analytics

N/A
256(40.6%)
Phase 2
165(26.2%)
Phase 1
84(13.3%)
Phase 4
53(8.4%)
Phase 3
51(8.1%)
Early Phase 1
21(3.3%)
630Total
N/A(256)
Phase 2(165)
Phase 1(84)
Phase 4(53)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (926)

Showing 20 of 926 trials
NCT07838714Phase 1Recruiting

Dual-Targeted Umbilical Cord Blood CAR-T Cells Against CD19 and CD22 for the Treatment of Relapsed or Refractory Acute B-Cell Lymphoblastic Leukemia

Role: lead

NCT03367676Phase 2Terminated

12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER)

Role: lead

NCT03324698Active Not Recruiting

The Natural History of Chronic Pancreatitis

Role: collaborator

NCT05397340Not ApplicableCompleted

Asymmetric Targeted DBS for PD With PIGD

Role: lead

NCT07834671Not Yet Recruiting

Research on Respiratory Support Decision-Making for Mechanically Ventilated ICU Patients Based on a Physiological World Model

Role: lead

NCT07582731Not ApplicableRecruiting

A Multi-Center Randomized Controlled Trial on the Impact of Disease Subtype-Based Active Video Education on Bowel Preparation Quality in Patients With Inflammatory Bowel Disease

Role: collaborator

NCT07824492Not ApplicableNot Yet Recruiting

Transcutaneous Regulation for Atrial Prevention in Postoperative Atrial Fibrillation Following OPCAB

Role: lead

NCT07824479Recruiting

Predicting Efficacy of Preoperative Immunotherapy in Advanced Gastric Cancer

Role: lead

NCT06146946Not ApplicableRecruiting

Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)

Role: collaborator

NCT07819175Not ApplicableNot Yet Recruiting

Pulsed Field Ablation for the Treatment of Persistent Atrial Fibrillation: Pulmonary Vein Plus Superior Vena Cava Isolation Versus Pulmonary Vein Isolation Alone-A Prospective, Multicenter, Randomized Controlled Study

Role: lead

NCT07022964Phase 1Recruiting

CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas

Role: collaborator

NCT07813260Recruiting

Screening for Urological Malignancies Using a Urine Exfoliated Cell Fluorescence Assay in a Hematuria Population

Role: lead

NCT06980935Not ApplicableCompleted

STN-tTIS Modulates Parkinson Motor Symptoms With and Without Medications

Role: lead

NCT06767891Enrolling By Invitation

Real-world Study of Acalabrutinib

Role: lead

NCT07806903Not Yet Recruiting

Electroencephalographic Trajectories During Emergence From Inhalational and Total Intravenous Anesthesia

Role: lead

NCT07804992Completed

Early Versus Deferred De-escalation From Controlled Ventilation After a 48-Hour Landmark of Physiological Stability

Role: lead

NCT07795528Recruiting

Postoperative Circulating Tumor DNA Monitoring in Stage I-III Driver-Mutant Colon Adenocarcinoma

Role: lead

NCT07003737Not ApplicableRecruiting

Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation

Role: collaborator

NCT07183878Not ApplicableRecruiting

Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)

Role: collaborator

NCT06802926Phase 4Recruiting

Pilot Trial of Colchicine for Graft Failure in CABG

Role: lead